Bright Minds Biosciences, Inc. (DRUG)
80.57
+2.65
(+3.40%)
USD |
NASDAQ |
Feb 12, 16:00
81.99
+1.42
(+1.76%)
After-Hours: 07:35
Bright Minds Biosciences Market Cap : 784.12M for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 929.27B |
| ACADIA Pharmaceuticals, Inc. | 3.656B |
| Alnylam Pharmaceuticals, Inc. | 40.75B |
| Savara, Inc. | 1.186B |
| BioMarin Pharmaceutical, Inc. | 11.52B |
Market Cap Related Metrics
| PEG Ratio | -0.453 |
| Price to Book Value | 13.30 |
| Price | 80.57 |
| Earnings Yield | -1.53% |
| PEGY Ratio | -0.453 |